Loading...
XASX
EZZ
Market cap14mUSD
Jul 10, Last price  
0.45AUD
1D
0.00%
1Q
-46.11%
IPO
-55.88%
Name

EZZ Life Science Holdings Ltd

Chart & Performance

D1W1MN
XASX:EZZ chart
P/E
3.15
P/S
0.32
EPS
0.14
Div Yield, %
8.89%
Shrs. gr., 5y
1.95%
Rev. gr., 5y
31.03%
Revenues
67m
+0.65%
11,187,44717,315,19122,287,07815,022,02637,143,33066,443,37166,873,691
Net income
7m
-3.36%
823,8101,586,1312,030,6061,312,4183,629,7276,964,4886,730,441
CFO
4m
-29.14%
416,3292,974,385253,5331,901,7304,014,2596,143,8514,353,320
Dividend
Nov 24, 20250.02 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

EZZ Life Science Holdings Limited, an Australian company, specializes in offering a range of skincare and consumer health products, with its market presence extending across Australia, New Zealand, Mainland China, and other international territories. The company's operations are divided into two distinct segments: 'Brought in Lines' and 'Company Owned products.' EZZ is actively involved in the wholesale supply of its EAORON-branded skincare portfolio, distributing it to pharmacies, major supermarkets, specialist retailers, and general grocery stores. Furthermore, the company designs, develops, manufactures, and markets a comprehensive selection of consumer health products under its own EZZ brand. This extensive offering includes vitamins, dietary supplements, sports nutrition, weight management and wellbeing solutions, traditional herbal remedies, and paediatric lines. These EZZ-branded items are sold directly to consumers via its e-commerce platforms and various retail stores, notably Tmall Global. Founded in 2015, EZZ Life Science Holdings Limited maintains its corporate headquarters in Silverwater, Australia.
IPO date
Mar 03, 2021
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT